EDGAR Filing Documents for 0001104659-19-036034

Form 8-K/A - Current report: [Amend]

SEC Accession No. 0001104659-19-036034

Filing Date

2019-06-18

Accepted

2019-06-18 06:37:26

Documents

Period of Report

2019-06-14

Items

Item 1.02: Termination of a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K/A	a19-11671_18ka.htm	8-K/A	42420
2	EX-99.1	a19-11671_1ex99d1.htm	EX-99.1	17778
3	EX-99.2	a19-11671_1ex99d2.htm	EX-99.2	39926
4	EX-99.3	a19-11671_1ex99d3.htm	EX-99.3	27405
5	GRAPHIC	g116711mmi001.jpg	GRAPHIC	2783
6	GRAPHIC	g116711mqi001.jpg	GRAPHIC	2863
7	GRAPHIC	g116711moi001.jpg	GRAPHIC	2920
	Complete submission text file	0001104659-19-036034.txt		141042

Mailing Address C/O MOURANT GOVERNANCE SERVICES (CAYMAN) 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108

Business Address C/O MOURANT GOVERNANCE SERVICES (CAYMAN) 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108 13459494123

BeiGene, Ltd. (Filer) CIK: 0001651308 (see all company filings)

IRS No.: 981209416 | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-37686 | Film No.: 19902616
SIC: 2834 Pharmaceutical Preparations